Chemotherapy Followed by Surgery Versus Chemoradiotherapy for Locally Advanced Cervical Cancer
For women diagnosed with locally advanced cervical cancer, the choice between primary chemoradiotherapy and chemotherapy followed by surgery remains a subject of clinical debate.
A systematic review current to May 2026, published by Cochrane, evaluated whether surgical intervention following chemotherapy offers a viable alternative to the standard concurrent chemoradiotherapy approach.
Key Clinical Takeaways:
- Five-year survival rates show little to no measurable difference between patients treated with chemotherapy followed by surgery and those receiving standard chemoradiotherapy.
- Patients undergoing chemotherapy followed by surgery likely experience a higher frequency of serious short-term adverse effects.
- Current evidence is not enough to show whether surgery changes the rate of cancer recurrence or disease progression.
Clinical data from 1,259 women across two studies indicate that overall survival at the five-year mark does not significantly differ based on the treatment modality.
While chemoradiotherapy is the established standard of care for locally advanced disease—where the tumor has invaded surrounding tissues but not spread to distant sites—the reliance on radiation equipment presents a hurdle in resource-limited settings. Researchers investigated whether surgical resection could circumvent these infrastructure limitations without compromising long-term outcomes.
The safety profile of these two approaches reveals a distinct contrast in patient experience. Data from 1,224 women suggest that the surgical arm of treatment is associated with a higher incidence of serious short-term unwanted effects compared to the chemoradiotherapy group. While long-term morbidity data remain uncertain, partially due to the evolution of radiotherapy techniques since the inception of the analyzed studies, the immediate clinical burden of surgery appears more pronounced.
| Outcome Metric | Patient Sample (Total) | Clinical Finding |
|---|---|---|
| Five-Year Survival | 1,259 | Little to no difference |
| Short-Term Adverse Effects | 1,224 | Higher in surgery group |
| Quality of Life (2 Years) | 239 | Little to no difference |
Assessing the risk of disease recurrence remains difficult due to the limitations of existing research. Analyses of 635 women regarding recurrence and 626 women regarding disease progression yielded very low-confidence evidence.
One study suggested a potentially higher risk of disease worsening following chemotherapy and surgery, yet researchers emphasize that this conclusion remains highly uncertain. A major confounding factor in the review is that many participants in the surgery group later needed radiotherapy, making it hard to isolate the surgery's specific effect.
The three studies Cochrane identified, which included 1,326 women across India and 10 European countries, show a clear need for more rigorous, high-quality trials.
Because existing data are limited by older radiation techniques and cross-over treatments where surgery patients also received radiation, clinicians currently struggle to define the optimal patient profile for surgical intervention. Future investigations must prioritize standardized protocols to isolate the therapeutic value of surgery in the context of locally advanced cervical cancer management.
Cochrane was founded in 1993, emerging from a call for systematic reviews of all relevant randomized controlled trials in healthcare. The organization, which previously operated under the name the Cochrane Collaboration, is a British international charity that relies on a network of over 37,000 volunteer experts.
Its work is organized through 53 review groups based at research institutions worldwide, which publish findings in the Cochrane Library. The organization’s logo features a forest plot derived from an influential systematic review on the effects of antenatal corticosteroids, reflecting its commitment to synthesizing medical research to support evidence-based decision-making for health professionals, patients, and policy makers.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.